D47.1
Billable codeChronic myeloproliferative disease
The ICD-10 code for chronic myeloproliferative disease is D47.1.
Clinical notes
Excludes1 (not coded here)
An Excludes1 note is a pure exclusion: the excluded condition and this code should never be reported together, because the two conditions cannot occur at the same time (e.g. a congenital form vs. an acquired form of the same disease).
Also known as
Alternate wording, synonyms, or specific conditions that fall under this code, listed to help confirm you've picked the right one.
- Chronic neutrophilic leukemia
- Myeloproliferative disease, unspecified
Documentation support
General coding-documentation guidance — not a substitute for payer-specific requirements or professional coding judgment.
- •Confirm the excluded condition(s) listed above are not also present — Excludes1 conditions cannot be coded together with this one.
- •As a general rule, code to the highest level of specificity supported by the documentation in the medical record.
Related codes in this category
- D47.0Mast cell neoplasms of uncertain behaviornon-billable header
- D47.2Monoclonal gammopathy
- D47.3Essential (hemorrhagic) thrombocythemia
- D47.4Osteomyelofibrosis
- D47.9Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified
- D47.ZOther specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissuenon-billable header
- D47.1Chronic myeloproliferative disease
ICD-9-CM equivalent
Informational only — GEM mappings are approximate, not guaranteed one-to-one equivalents. Verify before use in billing.
- 23876Approximate match
- 23879Approximate match
Associated MS-DRGs
D47.1 can serve as the principal diagnosis for these Medicare Severity Diagnosis-Related Groups.
Informational only — actual DRG assignment also depends on procedures, complications/comorbidities (CC/MCC), discharge status, and payer-specific rules not reflected here.
- DRG 814Reticuloendothelial and Immunity Disorders with MCC
- DRG 815Reticuloendothelial and Immunity Disorders with CC
- DRG 816Reticuloendothelial and Immunity Disorders without CC/MCC
- DRG 820Lymphoma and Leukemia with Major O.R. Procedures with MCC
- DRG 821Lymphoma and Leukemia with Major O.R. Procedures with CC
- DRG 822Lymphoma and Leukemia with Major O.R. Procedures without CC/MCC
- DRG 823Lymphoma and Non-Acute Leukemia with Other Procedures with MCC
- DRG 824Lymphoma and Non-Acute Leukemia with Other Procedures with CC
- DRG 825Lymphoma and Non-Acute Leukemia with Other Procedures without CC/MCC
- DRG 840Lymphoma and Non-Acute Leukemia with MCC
- DRG 841Lymphoma and Non-Acute Leukemia with CC
- DRG 842Lymphoma and Non-Acute Leukemia without CC/MCC